Loading...
JUBLINGREA logo

Jubilant Ingrevia LimitedNSEI:JUBLINGREA Stock Report

Market Cap ₹111.7b
Share Price
₹706.20
My Fair Value
n/a
1Y6.5%
7D6.1%
Portfolio Value
​
View

Jubilant Ingrevia Limited

NSEI:JUBLINGREA Stock Report

Market Cap: ₹111.7b

Jubilant Ingrevia (JUBLINGREA) Stock Overview

Engages in life science products and solutions in India, the United States, Europe, China and internationally. More details

JUBLINGREA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Rewards

Trading at 0.1% below our estimate of its fair value

Earnings are forecast to grow 27.52% per year

Earnings grew by 64.1% over the past year

Risk Analysis

Dividend of 0.71% is not well covered by free cash flows


JUBLINGREA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

JUBLINGREA logo
Jubilant Ingrevia

Rising Green Chemistry Demand Will Reimagine Global Specialty Markets

Key Takeaways Rapid capacity expansion, strong product pipeline, and backward integration will drive sustained revenue growth, boosted margins, and long-term market leadership across key segments. Strategic focus on innovation, sustainable practices, and premium export markets positions the company for resilient, high-quality earnings amid global supply chain shifts.
View narrative
₹1.25k
FV
43.5% undervalued intrinsic discount
21.49%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
JUBLINGREA logo
Jubilant Ingrevia

Improved Margins And Board Meeting Will Shape Export Opportunity Outlook

Key Takeaways Expansion in specialty chemicals and nutrition, combined with new export opportunities and supply chain shifts, is fueling sustained growth and higher-margin revenues. Strategic investments, cost optimization, and backward integration are strengthening profitability and supporting the company's shift toward more resilient, value-added business segments.
View narrative
₹987.75
FV
28.5% undervalued intrinsic discount
15.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
JUBLINGREA logo
Jubilant Ingrevia

Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects

Key Takeaways Strengthening demand and export growth are offset by regulatory, supply chain, and technological risks that could threaten profitability and long-term revenue sustainability. Heavy capital requirements and product concentration heighten earnings volatility and may constrain the company's ability to capture future industry upswings.
View narrative
₹743
FV
5.0% undervalued intrinsic discount
18.60%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Jubilant Ingrevia Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Jubilant Ingrevia
Historical stock prices
Current Share Price₹706.20
52 Week High₹885.00
52 Week Low₹535.20
Beta0.30
1 Month Change0.98%
3 Month Change0.54%
1 Year Change6.46%
3 Year Change33.30%
5 Year Changen/a
Change since IPO162.82%

Recent News & Updates

Jubilant Ingrevia (NSE:JUBLINGREA) Shareholders Will Want The ROCE Trajectory To Continue

Nov 07
Jubilant Ingrevia (NSE:JUBLINGREA) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Jubilant Ingrevia Limited (NSE:JUBLINGREA) By 38%?

Oct 17
Are Investors Undervaluing Jubilant Ingrevia Limited (NSE:JUBLINGREA) By 38%?

Recent updates

Jubilant Ingrevia (NSE:JUBLINGREA) Shareholders Will Want The ROCE Trajectory To Continue

Nov 07
Jubilant Ingrevia (NSE:JUBLINGREA) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Jubilant Ingrevia Limited (NSE:JUBLINGREA) By 38%?

Oct 17
Are Investors Undervaluing Jubilant Ingrevia Limited (NSE:JUBLINGREA) By 38%?

The Price Is Right For Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Sep 20
The Price Is Right For Jubilant Ingrevia Limited (NSE:JUBLINGREA)

We Like These Underlying Return On Capital Trends At Jubilant Ingrevia (NSE:JUBLINGREA)

Jul 03
We Like These Underlying Return On Capital Trends At Jubilant Ingrevia (NSE:JUBLINGREA)

Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Pretty Bullish On The Stock After Recent Results

May 16
Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Pretty Bullish On The Stock After Recent Results

Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Share Price Matching Investor Opinion

Apr 22
Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Share Price Matching Investor Opinion
User avatar

International Expansion And New Vitamin B3 Facility Will Boost Presence In High-Value Products

Specialty Chemicals and Nutrition & Health segments are poised for growth, boosting revenue and margins through high-margin chemicals and vitamin B3 production.

Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50

Feb 01
Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50

Results: Jubilant Ingrevia Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Jan 31
Results: Jubilant Ingrevia Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Is Jubilant Ingrevia (NSE:JUBLINGREA) Using Too Much Debt?

Dec 18
Is Jubilant Ingrevia (NSE:JUBLINGREA) Using Too Much Debt?

We Think Jubilant Ingrevia (NSE:JUBLINGREA) Is Taking Some Risk With Its Debt

Sep 11
We Think Jubilant Ingrevia (NSE:JUBLINGREA) Is Taking Some Risk With Its Debt

Jubilant Ingrevia (NSE:JUBLINGREA) Is Reinvesting At Lower Rates Of Return

Aug 14
Jubilant Ingrevia (NSE:JUBLINGREA) Is Reinvesting At Lower Rates Of Return

Jubilant Ingrevia Limited Just Missed Earnings - But Analysts Have Updated Their Models

Jul 19
Jubilant Ingrevia Limited Just Missed Earnings - But Analysts Have Updated Their Models

Earnings Tell The Story For Jubilant Ingrevia Limited (NSE:JUBLINGREA) As Its Stock Soars 29%

Apr 13
Earnings Tell The Story For Jubilant Ingrevia Limited (NSE:JUBLINGREA) As Its Stock Soars 29%

Jubilant Ingrevia Limited Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

Feb 02
Jubilant Ingrevia Limited Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Feb 01
A Look At The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Returns At Jubilant Ingrevia (NSE:JUBLINGREA) Are On The Way Up

Oct 19
Returns At Jubilant Ingrevia (NSE:JUBLINGREA) Are On The Way Up

Market Cool On Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Earnings

Jun 08
Market Cool On Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Earnings

Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50

Feb 03
Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50

Investors Should Be Encouraged By Jubilant Ingrevia's (NSE:JUBLINGREA) Returns On Capital

Dec 14
Investors Should Be Encouraged By Jubilant Ingrevia's (NSE:JUBLINGREA) Returns On Capital

Calculating The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Oct 07
Calculating The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Jubilant Ingrevia Limited Just Missed Revenue By 86%: Here's What Analysts Think Will Happen Next

May 22
Jubilant Ingrevia Limited Just Missed Revenue By 86%: Here's What Analysts Think Will Happen Next

Shareholder Returns

JUBLINGREAIN ChemicalsIN Market
7D6.1%1.6%1.3%
1Y6.5%3.0%6.2%

Return vs Industry: JUBLINGREA exceeded the Indian Chemicals industry which returned 3% over the past year.

Return vs Market: JUBLINGREA matched the Indian Market which returned 6.2% over the past year.

Price Volatility

Is JUBLINGREA's price volatile compared to industry and market?
JUBLINGREA volatility
JUBLINGREA Average Weekly Movement4.3%
Chemicals Industry Average Movement4.7%
Market Average Movement5.2%
10% most volatile stocks in IN Market8.6%
10% least volatile stocks in IN Market3.1%

Stable Share Price: JUBLINGREA has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: JUBLINGREA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20192,139Deepak Jainjubilantingrevia.com

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions.

Jubilant Ingrevia Limited Fundamentals Summary

How do Jubilant Ingrevia's earnings and revenue compare to its market cap?
JUBLINGREA fundamental statistics
Market cap₹111.67b
Earnings (TTM)₹2.88b
Revenue (TTM)₹42.67b
38.8x
P/E Ratio
2.6x
P/S Ratio

Is JUBLINGREA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JUBLINGREA income statement (TTM)
Revenue₹42.67b
Cost of Revenue₹22.36b
Gross Profit₹20.31b
Other Expenses₹17.43b
Earnings₹2.88b

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)18.21
Gross Margin47.60%
Net Profit Margin6.75%
Debt/Equity Ratio26.1%

How did JUBLINGREA perform over the long term?

See historical performance and comparison

Dividends

0.7%
Current Dividend Yield
31%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 00:51
End of Day Share Price 2025/11/18 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jubilant Ingrevia Limited is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAsian Markets Securities Private Limited
Satish KumarCGS International
Siddharth GadekarEquirus Securities Private Limited